Skip to content

Clinical trials

Completed Carcinoma, Ovarian Epithelial trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Status: Completed Country / region: United States Clear all

324 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200016
200120
200213
200316
200430
200523
200621
200720
20086
200910
201010
20119
20129
20137
20144
20156
20167
20174
20195
20202
20213
20224
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed324

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)53
Fred Hutchinson Cancer Center21
Gynecologic Oncology Group21
Memorial Sloan Kettering Cancer Center21
City of Hope Medical Center9
University of Washington7
Case Comprehensive Cancer Center6
NYU Langone Health6
Wake Forest University Health Sciences6
Ludwig Institute for Cancer Research5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial324
Ovarian Neoplasms182
Fallopian Tube Neoplasms129
Breast Neoplasms82
Carcinoma, Non-Small-Cell Lung46
Precursor Cell Lymphoblastic Leukemia-Lymphoma41
Leukemia, Lymphocytic, Chronic, B-Cell40
Lymphoma, Follicular40
Lymphoma, Large B-Cell, Diffuse40
Burkitt Lymphoma39

Trials

Showing 1 to 25 of 324. Each trial links to its page on Pharma Observatory.

224 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.